Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inpatient Penicillin Delabeling for Low-Risk Patients

NCT06414694 is registered in ClinicalTrials.gov with University of Tennessee as lead sponsor.

NCT NCT06414694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inpatient Penicillin Delabeling for Low-Risk Patients
Lead sponsor
University of Tennessee
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2023
Completion date
September 30, 2025
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug allergy, penicillin